ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
12/31/2025
Back to search
Official data from USPTO
XENTIENT
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
20
Latest update
01/01/2026
Trademark type
Combined
Nice classes
42
Filing date
12/27/2024
Registration date
12/23/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/23/2025
Last transaction
01/01/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Foreign priority
Drawing code
5
Owner type
99
Owner location
SHANGHAI, CN
Examiner
CANFIELD III,JOSEPH J
Law office
L50
Current location
FILE REPOSITORY (FRANCONIA)
Mark description
The mark consists of stylized letters "Xentient".
Holders and representatives
Holders
SHANGHAI AILUX BIOTECHNOLOGY CO., LTD.
Jingtai Zhiyao Technology (Shanghai) Co., Ltd.
Representatives
Alex Patel Patel IP, P.C.
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Biochemical research and analysis; Design of computer-simulated models; DNA screening for scientific research purposes; Pharmaceutical research and development; Platform as a service (PAAS) featuring computer software platforms for scientific researchsoftware for conducting preclinical research by analyzing and managing data that is necessary for pharmaceutical drug development and antibody development; Research and development of new products for others; Research in the field of artificial intelligence; Software as a service (SAAS) services featuring software for scientific researchsoftware for conducting preclinical research by analyzing and managing data that is necessary for pharmaceutical drug development and antibody development; Software engineering services; Working on and evaluation of chemical syntheses
Publications
History of USPTO decisions and trademark events.
20 publications found
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
12/23/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
12/23/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/04/2025
PUBO
PUBLISHED FOR OPPOSITION
11/04/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/29/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/04/2025
XAEC
EXAMINER'S AMENDMENT ENTERED
09/29/2025
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
09/29/2025
GNEA
EXAMINERS AMENDMENT E-MAILED
09/29/2025
CNEA
EXAMINERS AMENDMENT -WRITTEN
09/29/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/20/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/19/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/19/2025
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
06/16/2025
GNRT
NON-FINAL ACTION E-MAILED
06/16/2025
CNRT
NON-FINAL ACTION WRITTEN
06/16/2025
DOCK
ASSIGNED TO EXAMINER
06/11/2025
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/02/2025
NWAP
NEW APPLICATION ENTERED
12/27/2024
Continuous trademark protection
Get notified about every new filing that threatens XENTIENT or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.